Point72 Asset Management, L.P. - LEXICON PHARMACEUTICALS INC ownership

LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 113 filers reported holding LEXICON PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 3.02 and the average weighting 0.1%.

Quarter-by-quarter ownership
Point72 Asset Management, L.P. ownership history of LEXICON PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$1,254,771
-51.1%
516,367
-61.6%
0.00%
-55.6%
Q4 2022$2,567,290
-70.4%
1,344,131
-62.8%
0.01%
-74.3%
Q3 2022$8,672,000
+445.4%
3,613,500
+584.2%
0.04%
+250.0%
Q3 2019$1,590,000
-71.0%
528,100
+38.1%
0.01%
-67.7%
Q1 2017$5,485,000382,5000.03%
Other shareholders
LEXICON PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Ulys, L.L.C. 4,321,214$25,366,000100.00%
Artal Group S.A. 71,178,364$417,817,0007.38%
BVF INC/IL 8,394,000$49,273,0001.85%
Boothe Investment Group, Inc. 435,939$2,559,0001.49%
Campbell & CO Investment Adviser LLC 103,100$605,0000.37%
NEA Management Company, LLC 2,382,286$13,984,0000.31%
PINNACLE ASSOCIATES LTD 2,167,172$12,721,0000.24%
Eversept Partners, LP 410,593$2,410,1810.18%
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO 35,714$210,0000.12%
OCCUDO QUANTITATIVE STRATEGIES LP 66,299$389,0000.08%
View complete list of LEXICON PHARMACEUTICALS INC shareholders